Skip to main content
Clinical Trials/IRCT20231023059817N4
IRCT20231023059817N4
Not yet recruiting
Phase 3

Comparing the therapeutic effects of two methods of injectable iron and oral iron on quality of life, sleep quality, and breastfeeding self-efficacy in women with iron deficiency/ iron deficiency anemia in the postpartum period (postpartum)

Zistaroo Danesh Company0 sites170 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Zistaroo Danesh Company
Enrollment
170
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Zistaroo Danesh Company

Eligibility Criteria

Inclusion Criteria

  • Mothers who have hemoglobin between 9 and 10\.5 g/dl after giving birth.
  • Having informed consent

Exclusion Criteria

  • History of anemia due to reasons other than iron deficiency and blood loss during pregnancy or being pregnant
  • The presence of more bleeding than usual postpartum (after the first 24 hours, more than menses or passing a large clot)
  • Severe active infection
  • Having a history of allergy to injectable iron
  • The presence of systemic disease in the mother (patients who received erythropoiesis stimulator (erythropoietin) during the last 3 months, patients who received myelosuppressive treatment and blood or blood products during delivery, patients with asthma under treatment, patients with hepatitis, Patients with HIV, patients with blood problems other than iron deficiency, patients with IBD, patients with CKD (eGFR\<60\)
  • Having a history of sleep disorder or depression and mothers who need to receive antidepressants.
  • Mothers who have suffered the death of a fetus or baby
  • Taking PPI, H2 blocker and antihistamine

Outcomes

Primary Outcomes

Not specified

Similar Trials